Autoimmune cholestatic liver disease in people with coeliac disease: A population-based study of their association

Alimentary Pharmacology and Therapeutics

Volumn 21, Issue 4, 2005, Pages 401-405

  Lawson, A ^a   West, J ^a,b   Aithal, G P ^a   Logan, R F A ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; CELIAC DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OBSTRUCTIVE JAUNDICE; POPULATION RESEARCH; PREVALENCE; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RISK ASSESSMENT;

ADULT; AGED; AUTOIMMUNE DISEASES; CELIAC DISEASE; CHOLANGITIS, SCLEROSING; EPIDEMIOLOGIC METHODS; FEMALE; GREAT BRITAIN; HUMANS; LIVER CIRRHOSIS, BILIARY; MALE; MIDDLE AGED;

EID: 14644412830     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2005.02328.x     Document Type: Article

References (23)

1. Sorensen HT, Thulstrup AM, Blomqvist P, et al. Risk of primary biliary liver cirrhosis in patients with coeliac disease: Danish and Swedish cohort data. Gut 1999; 44: 736-8.
2. Fidler HM, Butler P, Burroughs N, et al. Co-screening for primary biliary cirrhosis and coeliac disease. Primary biliary cirrhosis and coeliac disease: a study of relative prevalences. Gut 1998; 43: 300.
3. Logan RF, Ferguson A, Finlayson ND, et al. Primary biliary cirrhosis and coeliac disease: an association? Lancet 1978; 1: 230-3.
4. Dickey W, McMillan SA, Callender ME. High prevalence of celiac sprue among patients with primary biliary cirrhosis. J Clin Gastroenterol 1997; 25: 328-9.
5. Fine KD, Ogunji F, Saloum Y, et al. Celiac sprue: another autoimmune syndrome associated with hepatitis C. Am J Gastroenterol 2001; 96: 138-45.
6. Hay JE, Wiesner RH, Shorter RG, et al. Primary sclerosing cholangitis and celiac disease. A novel association. Ann Intern Med 1988; 109: 713-7.
7. Volta U, De Franceschi L, Molinaro N, et al. Frequency and significance of anti-gliadin and anti-endomysial antibodies in autoimmune hepatitis. Dig Dis Sci 1998; 43: 2190-5.
8. Volta U, Rodrigo L, Granito A, et al. Celiac disease in autoimmune cholestatic liver disorders. Am J Gastroenterol 2002; 97: 2609-13.
9. Schrumpf E, Abdelnoor M, Fausa O, et al. Risk factors in primary sclerosing cholangitis. J Hepatol 1994; 21: 1061-6.
10. Bardella MT, Quatrini M, Zuin M, et al. Screening patients with celiac disease for primary biliary cirrhosis and vice versa. Am J Gastroenterol 1997; 92: 1524-6.
11. Kingham JG, Parker DR. The association between primary biliary cirrhosis and coeliac disease: a study of relative prevalences. Gut 1998; 42: 120-2.
12. Gillett HR, Cauch-Dudek K, Jenny E, et al. Prevalence of IgA antibodies to endomysium and tissue transglutaminase in primary biliary cirrhosis. Can J Gastroenterol 2000; 14: 672-5.
13. Habior A, Lewartowska A, Orlowska J, et al. Association of coeliac disease with primary biliary cirrhosis in Poland. Eur J Gastroenterol Hepatol 2003; 15: 159-64.
14. Floreani A, Betterle C, Baragiotta A, et al. Prevalence of coeliac disease in primary biliary cirrhosis and of antimitochondrial antibodies in adult coeliac disease patients in Italy. Dig Liver Dis 2002; 34: 258-61.
15. Walley T, Mantgani A. The UK General Practice Research Database. Lancet 1997; 350: 1097-9.
16. West J, Logan RF, Card TR, et al. Fracture risk in people with celiac disease: a population-based cohort study. Gastroenterology 2003; 125: 429-36.
17. Howel D, Fischbacher CM, Bhopal RS, et al. An exploratory population-based case-control study of primary biliary cirrhosis. Hepatology 2000; 31: 1055-60.
18. Austin AS, Logan RF, Thomason K, et al. Cigarette smoking and adult coeliac disease. Scand J Gastroenterol 2002; 37: 978-82.
19. James OF, Bhopal R, Howel D, et al. Primary biliary cirrhosis once rare, now common in the United Kingdom? Hepatology 1999; 30: 390-4.
20. Bambha K, Kim WR, Talwalkar J, et al. Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology 2003; 125: 1364-9.
21. Lewis JD, Brensinger C, Bilker WB, et al. Validity and completeness of the General Practice Research Database for studies of inflammatory bowel disease. Pharmacoepidemiol Drug Saf 2002; 11: 211-8.
22. Korponay-Szabo IR, Halttunen T, Szalai Z, et al. In vivo targeting of intestinal and extraintestinal transglutaminase 2 by coeliac autoantibodies. Gut 2004; 53; 641-8.
23. Neuberger J. PBC and the gut: the villi atrophy, the plot thickens. Gut 1999; 44: 594-5.